GXE:ETR
Lakefront Biotherapeutics NV
€26.28
arrow_downward
-0.83%(-0.22) 1D
Oct 13, 5:35:58 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€26.40
High
€26.46
Low
€26.22
Mkt. cap
1.73B
Avg. vol.
523.00
Volume
913.00
P/E ratio
2.90
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
Open
€26.40
High
€26.46
Low
€26.22
Mkt. cap
1.73B
Avg. vol.
523.00
Volume
913.00
P/E ratio
2.90
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
News stories
From web sources and news partners
BigGo Finance
·
26 minutes ago
Options Market Warns of "Calm Before the Storm" — S&P 500 Daily Swings Seen Widening 50% From Late October
Stocktwits
·
20 minutes ago
UNH Stock Outpaces S&P 500 In 2026, Eyes Best Year Since Pandemic — CFO Says Wall Street May Be Missing 2027 Upside
Yahoo Finance
·
41 minutes ago
The S&P 500 Just Hit a Record High. Here's Why History Says It's Still a Smart Time to Invest.
www.marketscreener.com
·
1 hour ago
S&P 500 index edged higher after Stockholm Stock Exchange close on Tuesday
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com